TL;DR: Oral terbinafine delivers the highest cure rate at 38% complete clearance versus 14% for itraconazole and just 6.5-17.8% for topical prescriptions. Generic terbinafine costs $15-45 for a full 12-week course, while topical options like efinaconazole run $4,000+ for 48 weeks of treatment. Best for: adults with confirmed fungal infection affecting more than 50% of the nail who can tolerate oral medication.
Your doctor prescribed that topical solution six months ago. You've applied it religiously every single day. The nail still looks terrible.
You're not alone. Medicalnewstoday, topical antifungals like tavaborole achieve just a 6.5% complete cure rate. Even the "better" topical option, efinaconazole, only reaches 17.8% complete clearance.
The prescription nail fungus market generates Mdedge in the United States, yet most patients never achieve clear nails. The disconnect stems from three factors: misdiagnosis (up to 50% of discolored nails aren't fungal), inadequate treatment duration, and poor patient selection for specific therapies.
The problem isn't your application technique. It's biology.
Nail fungus lives under the nail plate—a thick, protective barrier made of keratin. Topical medications sit on top. They can't penetrate deep enough to reach the infection at its source. Meanwhile, the fungus continues spreading through the nail bed, matrix, and surrounding tissue.
Oral antifungals work differently. They enter your bloodstream, travel to the nail bed through tiny blood vessels, and attack the fungus from underneath as new nail grows out. This is why Medicalnewstoday—more than double the best topical option.
But "38%" still means most people don't get completely clear nails. Why such modest numbers?
The answer involves treatment duration, patient adherence, reinfection rates, and the fundamental challenge of eradicating fungus from a structure that grows at just 1.6mm per month. According to research published by Feet Made Simple, toenails take 12-18 months to fully replace—even after the fungus is killed.
Key Takeaway: Topical prescriptions achieve 6.5-17.8% cure rates because they can't penetrate the nail plate. Oral terbinafine reaches 38% by attacking fungus through the bloodstream, but complete clearance still takes 12-18 months of nail regrowth.
Prescription treatments for nail fungus fall into three categories: oral antifungals (pills taken daily or intermittently), topical prescription solutions (applied directly to nails), and combination approaches that use both simultaneously.
, onychomycosis affects over 20% of adults over age 60 and more than 50% of people over age 70. Dermatophytes account for 90% of toenail infections and 50% of fingernail infections. These fungi burrow deep into the nail bed and matrix—far below where topical treatments can reach effectively.
You need prescription treatment when over-the-counter options have failed, when the infection affects more than 50% of the nail, or when the fungus has reached the nail matrix (the growth center under your cuticle). According to the CDC, nail fungus infections can take several months to a year to resolve even with prescription medication.
Oral antifungals include terbinafine (Lamisil), itraconazole (Sporanox), and fluconazole (Diflucan). These medications circulate through your bloodstream and concentrate in the nail bed as new nail grows. Mayo Clinic reports you typically take these drugs daily for 6 to 12 weeks, though it may take four months or longer to eliminate the infection completely.
Topical prescription solutions include efinaconazole (Jublia), tavaborole (Kerydin), and ciclopirox (Penlac). You apply these directly to affected nails, usually daily. Mayoclinic, you may need to use topical nail polish formulations daily for almost a year.
Combination therapy pairs oral medication with topical treatment. This dual approach targets the fungus from both inside (through bloodstream) and outside (direct application), potentially improving cure rates for severe infections.
The choice between these options depends on infection severity, your overall health, potential drug interactions, and cost considerations. Oral medications work faster but require liver monitoring. Topical treatments avoid systemic side effects but demand longer treatment periods with lower success rates.
Key Takeaway: Prescription nail fungus treatments include oral antifungals (38% cure rate, 12 weeks), topical solutions (6.5-17.8% cure rate, 48 weeks), and combination therapy. Oral medications work through bloodstream; topicals apply directly but penetrate poorly.
Terbinafine dominates the prescription landscape for good reason: it delivers the highest cure rate with the shortest treatment duration.
Medical News Today reports terbinafine achieves a 38% complete cure rate—meaning the nail looks completely clear with no fungus detected on lab testing. You take 250mg daily for 12 weeks for toenails or 6 weeks for fingernails.
Itraconazole comes in second at 14% complete cure rate. The advantage? Pulse therapy. Instead of daily pills for three months, you take 200mg twice daily for just one week per month, repeating for 3-4 months. That's only 21-28 total days of medication versus 84 days with terbinafine.
Fluconazole trails both options but offers the fewest drug interactions. It's prescribed off-label for nail fungus (not FDA-approved for this use) at 150-450mg weekly for 6-12 months.
Treatment Duration Comparison:
MedicationDaily DoseDurationTotal PillsComplete Cure RateTerbinafine250mg12 weeks (toenails)8438%Itraconazole200mg BID1 week/month × 3-4 months42-5614%Fluconazole150-450mg weekly6-12 months24-48Lower than 14%
The cure rate gap matters. If you're investing time, money, and potential side effects into treatment, terbinafine's 38% success rate versus itraconazole's 14% represents a 2.7× improvement in your odds of completely clear nails.
Side Effects to Monitor:
All three medications can cause liver enzyme elevations. Your doctor will order baseline liver function tests before starting treatment and may recheck them at 6 weeks. According to Scripps Health, you may need to treat for six months or more to clear the infection, though this typically refers to the time until nails look completely clear—not the medication duration itself.
Terbinafine can alter taste perception (temporarily affecting 2.8% of patients) and rarely causes severe skin reactions. Itraconazole carries a black box warning for heart failure—it's contraindicated if you have any history of congestive heart failure. Fluconazole has the mildest side effect profile but requires the longest treatment course.
Drug Interactions:
Itraconazole inhibits CYP3A4 enzymes, creating serious interactions with statins, blood thinners, certain heart medications, and many other drugs. Terbinafine inhibits CYP2D6, affecting some antidepressants and beta-blockers but causing fewer problematic interactions overall. Fluconazole has minimal CYP enzyme effects.
If you take multiple medications—especially statins, warfarin, or heart drugs—terbinafine or fluconazole may be safer choices than itraconazole.
Key Takeaway: Terbinafine delivers 38% complete cure in 12 weeks versus itraconazole's 14% in 3-4 months of pulse therapy. All require liver monitoring, but itraconazole has the most serious drug interactions and is contraindicated with heart failure.
The price gap between oral and topical prescriptions is staggering—and it's not what you'd expect.
Generic terbinafine costs $15-45 for a complete 12-week course using discount cards. That's the entire treatment. Brand-name Lamisil costs significantly more—often $500+—but generic versions work identically.
Topical prescriptions? Prepare for sticker shock.
Efinaconazole (Jublia) runs approximately $600-800 per 4ml bottle—enough for 6-8 weeks of treatment. You need 6-7 bottles for the full 48-week course. Total cost: $4,000-4,700 without insurance.
Tavaborole (Kerydin) costs $600-700 per 10ml bottle. The 48-week treatment requires 3-4 bottles, totaling $1,800-2,800.
Ciclopirox (Penlac) is the "affordable" topical at roughly $300-400 for a 48-week supply, but Medical News Today reports it achieves only an 8.5% complete cure rate—the lowest of all prescription options.
Cost Per Month Breakdown:
TreatmentMonthly Cost (Cash)Total Treatment CostCure RateTerbinafine (generic)$5-15$15-45 (12 weeks)38%Itraconazole (generic)$70-90$280-360 (4 months)14%Efinaconazole (Jublia)$800-1,000$4,000-4,700 (48 weeks)17.8%Tavaborole (Kerydin)$150-200$1,800-2,800 (48 weeks)6.5%Ciclopirox (Penlac)$25-35$300-400 (48 weeks)8.5%
Insurance Coverage Reality:
Most insurance plans cover generic terbinafine with minimal copays ($5-30 for a 90-day supply). Itraconazole is also typically covered but may require prior authorization.
Topical prescriptions face significant coverage barriers. Many plans don't cover them at all or require documented failure of oral therapy first. When covered, copays often exceed $100-300 per bottle.
Manufacturer copay cards can reduce out-of-pocket costs for commercially insured patients—sometimes to $0-50 per prescription. But these cards don't work with Medicare, Medicaid, or if you're uninsured.
Hidden Costs:
Don't forget lab monitoring. Liver function tests cost $25-75 per test. You'll need baseline testing before starting oral antifungals, possibly a recheck at 6 weeks, and potentially another test if you have symptoms. Budget $50-150 for monitoring labs.
The cost-effectiveness calculation is clear: terbinafine delivers 38% cure rate for $15-45 plus $50-150 in labs. Efinaconazole delivers 17.8% cure rate for $4,000-4,700 with no lab monitoring needed. You're paying 100× more for half the success rate.
Key Takeaway: Generic terbinafine costs $15-45 total (12 weeks) with 38% cure rate. Topical efinaconazole costs $4,000-4,700 (48 weeks) with 17.8% cure rate. Insurance typically covers oral medications but often denies topical prescriptions.
The short answer: barely.
, efinaconazole (Jublia) achieves a complete cure rate of 17.8%—the highest among topical prescriptions. Tavaborole (Kerydin) manages just 6.5%. Ciclopirox (Penlac) reaches 8.5%.
These numbers represent "complete cure"—meaning the nail looks entirely clear AND lab testing shows no fungus. If you lower the bar to "mycological cure" (fungus gone but nail still looks abnormal), the rates improve to 47-55% for efinaconazole. But who wants to spend a year treating their nail only to have it still look discolored and thickened?
Why Topicals Fail:
The nail plate is a fortress. It's designed to protect your finger or toe from trauma. That same protective quality makes it nearly impermeable to topical medications.
Efinaconazole penetrates better than older formulations—that's why it outperforms tavaborole and ciclopirox. But "better penetration" still means most of the medication sits on the nail surface rather than reaching the infection underneath.
When Topical Makes Sense:
Despite poor cure rates, topical prescriptions have legitimate use cases:
Drug interactions: If you take medications that interact dangerously with oral antifungals (especially with itraconazole's extensive CYP3A4 interactions)
Liver disease: Patients with hepatitis, cirrhosis, or elevated liver enzymes can't take oral antifungals. Topical agents have minimal systemic absorption.
Mild infection: Less than 50% nail involvement without matrix infection may respond to topical treatment
Pregnancy/breastfeeding: Oral antifungals are Category C in pregnancy; topicals have minimal systemic absorption
Patient preference: Some people refuse oral medication due to side effect concerns
Application Requirements:
Topical prescriptions demand perfect adherence. You must:
, after seven days with ciclopirox, you wipe the piled-on layers clean with alcohol and begin fresh applications. Miss applications regularly and your already-low cure rate drops further.
Key Takeaway: Topical prescriptions achieve 6.5-17.8% complete cure rates after 48 weeks of daily application. They're appropriate for patients who can't take oral medications due to drug interactions, liver disease, or pregnancy—not as first-line treatment for most infections.
Pairing oral and topical antifungals improves outcomes beyond monotherapy alone. Healthevolves, combination therapy achieves the highest success rates and lowers recurrence risk.
The rationale is sound: oral medication attacks from inside through the bloodstream while topical treatment provides additional antifungal activity at the nail surface. This dual approach may push cure rates above 50% for severe infections.
Typical Combination Protocol:
Terbinafine 250mg daily for 12 weeks plus efinaconazole or ciclopirox applied daily throughout oral treatment and for several months after. The topical component provides sustained antifungal activity during the vulnerable regrowth period, addressing both active infection and preventing recolonization.
When Combination Therapy Makes Sense:
Previous oral monotherapy failed and infection returned within 6-12 months
Infection is severe, affecting more than 75% of nail plate with matrix involvement
Patient has diabetes or immunosuppression, which increases treatment failure rates
Recurrence after prior successful treatment—adding topical prevents reinfection
Patient prioritizes maximum efficacy over cost considerations
The Cost Barrier:
Combination therapy means paying for both medications—potentially $4,000+ for topical plus $15-45 for oral plus monitoring labs. Total treatment cost jumps from $65-195 for oral alone to $4,133-4,941.
Insurance rarely covers this approach without documented failure of oral monotherapy first. Expect extensive prior authorization requirements and possible denials even after demonstrating treatment failure.
For treatment-resistant cases, the 15-20 percentage point improvement in cure rates may justify the cost. For most patients with first-time infections, oral terbinafine monotherapy remains the evidence-based starting point.
Key Takeaway: Combination therapy improves cure rates by 15-20 percentage points but costs $4,000+ versus $65-195 for oral alone. Reserve for severe infections, treatment failures, or patients with diabetes/immunosuppression. Insurance approval requires documented oral therapy failure.
Here's what your doctor probably didn't explain clearly: finishing your prescription doesn't mean your nail will look normal.
, it may take four months or longer to eliminate an infection even after completing oral medication. The fungus might be dead, but the damaged nail remains until it grows out completely.
The Timeline Reality:
Toenails grow at approximately 1.6mm per month. Your big toenail is roughly 20-25mm from cuticle to free edge. Do the math: complete regrowth takes 12-18 months.
You take terbinafine for 12 weeks. The medication kills the fungus during those three months. But you're looking at another 9-15 months of waiting for the clear nail to grow out and replace the damaged, discolored nail.
When to Expect Visible Improvement:
Weeks 1-12: Taking medication, no visible change (fungus dying but damaged nail still present)
Months 3-6: Clear nail begins growing from cuticle, but most of nail still looks infected
Months 6-12: Clear nail reaches halfway point, nail appearance improving
Months 12-18: Complete nail replacement, final assessment of cure
Research from Feet Made Simple confirms toenails creep at roughly 1.6mm per month, so a big toe takes 12-18 months to fully replace.
Fingernails vs Toenails:
Fingernails grow three times faster—about 3-4mm per month. That's why terbinafine treatment for fingernails is only 6 weeks versus 12 weeks for toenails. Complete fingernail regrowth takes 4-6 months instead of 12-18 months.
Follow-Up Testing Schedule:
Your doctor should recheck your nail at:
6 months post-treatment: Assess nail growth, confirm fungus hasn't returned. Mycological testing at this point confirms cure before discontinuing monitoring.
12 months post-treatment: Final evaluation once nail has fully regrown
Some providers do mycological testing (fungal culture or PCR) at the 6-month mark to confirm the fungus is truly eradicated before the nail looks completely clear. This prevents unnecessary retreatment if the nail appearance is simply slow to improve.
Recurrence Rates:
According to Scripps Health, the recurrence rate can be as high as 40%. The fungus comes back because:
Reinfection from contaminated shoes, socks, or nail tools
Incomplete eradication of the original infection
Underlying risk factors (diabetes, poor circulation, immune suppression) remain unaddressed
Concurrent athlete's foot provides a reservoir for reinfection
Preventing recurrence requires treating any foot fungus, disinfecting footwear, using antifungal powder in shoes, keeping nails trimmed short, and avoiding walking barefoot in public areas.
Key Takeaway: Terbinafine kills fungus in 12 weeks, but complete nail regrowth takes 12-18 months for toenails (4-6 months for fingernails). Visible improvement begins at 3-6 months as clear nail grows from the cuticle. Recurrence rates reach 40% without preventive measures.
Oral antifungals aren't safe for everyone. Several conditions make these medications too risky.
Absolute Contraindications:
Active liver disease: Hepatitis, cirrhosis, or elevated baseline liver enzymes (AST or ALT >2x upper limit of normal) rule out oral antifungals
Congestive heart failure: Itraconazole has a black box warning for CHF—it can worsen heart failure or trigger it in susceptible patients due to negative inotropic effects
Pregnancy and breastfeeding: All oral antifungals are Category C (risk cannot be ruled out); treatment should wait until after delivery and nursing
Relative Contraindications (Use with Caution):
Multiple medications: Extensive drug interactions, especially with itraconazole's potent CYP3A4 inhibition
Age over 65: treatment success rates appear lower in adults over age 65
Kidney disease: Dose adjustments may be needed
Immunosuppression: Lower cure rates, higher recurrence risk
Critical Drug Interactions:
Itraconazole interacts dangerously with:
Statins (simvastatin, lovastatin, atorvastatin) risking rhabdomyolysis
Blood thinners (warfarin)
Heart medications (digoxin, calcium channel blockers, many others)
Benzodiazepines (triazolam, midazolam)
Many psychiatric medications
Terbinafine has fewer interactions but affects:
Certain antidepressants (SSRIs, tricyclics metabolized by CYP2D6)
Beta-blockers (metoprolol, carvedilol)
Antiarrhythmics (flecainide, propafenone)
Caffeine metabolism (minor)
If you take any prescription medications, your doctor must review the interaction profile before prescribing oral antifungals. For patients on complex medication regimens, topical treatment may be the only safe option despite lower cure rates.
Required Lab Tests:
Before starting oral antifungals:
Liver function tests (AST, ALT, alkaline phosphatase, bilirubin): Baseline required, recheck at 6 weeks if symptoms develop
Complete blood count: Some providers check this to establish baseline for rare neutropenia cases
Fungal culture or PCR: Confirms diagnosis before exposing you to medication risks
, up to 50% of nail dystrophy is non-fungal (psoriasis, lichen planus, trauma). Treating without confirmed diagnosis means unnecessary medication exposure.
Warning Signs During Treatment:
Stop medication and contact your doctor immediately if you develop:
Jaundice (yellowing of skin or eyes)
Dark urine or pale stools
Persistent nausea, vomiting, or abdominal pain
Unusual fatigue or weakness
Skin rash or blistering
Shortness of breath or leg swelling (especially with itraconazole)
Diabetes Considerations:
The CDC notes people with diabetes are at increased risk for returning nail infections. Diabetic patients can take oral antifungals but require:
More aggressive preventive measures post-treatment
Closer monitoring for secondary bacterial infections
Attention to foot care and circulation issues
Prompt treatment of any athlete's foot to prevent reinfection
Key Takeaway: Oral antifungals are contraindicated with active liver disease, heart failure (itraconazole), and pregnancy. Extensive drug interactions—especially with statins and heart medications—may require topical treatment instead. Baseline liver function tests are mandatory before starting treatment.
Getting prescription nail fungus treatment used to mean multiple doctor visits, lab work, and pharmacy trips. Telehealth has changed this process significantly.
Traditional In-Person Route:
Schedule appointment with primary care doctor or podiatrist (wait time: 1-4 weeks)
Office visit for examination and diagnosis ($100-200 without insurance)
Lab work for fungal culture/PCR ($50-150) and baseline liver function tests ($25-75)
Follow-up appointment to review results and get prescription (another 1-2 weeks)
Fill prescription at pharmacy
Return for 6-week liver function recheck if prescribed
Total time: 3-6 weeks from initial call to starting medication.
Telehealth Prescription Services:
Several platforms now offer online evaluation and prescription for nail fungus with 24-48 hour provider review. This approach works well for straightforward cases but has limitations—providers can't physically examine your nail, assess thickness, or perform in-person diagnostic testing.
When to Choose In-Person vs Telehealth:
Choose in-person evaluation if:
Infection affects multiple nails
Nail is severely thickened (>2mm) or dystrophic
You have diabetes, circulation problems, or immune suppression
You've failed previous treatment
You're unsure if it's actually fungus (could be psoriasis, lichen planus, or trauma)
Telehealth may work if:
Single nail affected
Mild to moderate infection (<50% nail involvement)
No complicating health conditions
Previous confirmed fungal diagnosis
STRIDE: Prescription Treatment Through Telehealth
STRIDE offers doctor-supervised prescription treatment for toenail fungus through an online platform. Their approach combines oral terbinafine with a prescription topical solution—the combination therapy that Health Evolves reports achieves the highest success rates.
The STRIDE DUO protocol uses pulse therapy for oral terbinafine, which provides the same clinical efficacy as continuous dosing but with lower side effects and reduced liver risk. This matters if you're concerned about the safety profile of oral antifungals.
Licensed U.S. providers review your case, order appropriate lab work if needed, and prescribe treatment when clinically appropriate. Medications arrive discreetly at your home—no pharmacy trips or awkward conversations.
This model works particularly well for patients who've failed over-the-counter treatments and need prescription-strength therapy but want to avoid multiple doctor visits. The medical supervision addresses safety concerns while the convenience factor improves adherence.
Key Takeaway: Telehealth platforms like STRIDE provide prescription nail fungus treatment through online evaluation, combining oral and topical therapy with medical supervision. Best for straightforward cases; severe infections or multiple complicating factors require in-person evaluation.
Direct Answer: Oral terbinafine (Lamisil) is the most effective prescription treatment, achieving a 38% complete cure rate after 12 weeks of daily 250mg dosing.
, terbinafine outperforms all other options including itraconazole (14% cure rate) and topical prescriptions (6.5-17.8% cure rates). The medication works by entering your bloodstream and concentrating in the nail bed as new nail grows, attacking the fungus from underneath rather than trying to penetrate the nail plate from above.
Direct Answer: Generic terbinafine costs $15-45 for a complete 12-week course using discount cards like GoodRx, making it one of the most affordable prescription treatments available.
This price covers 90 tablets (250mg daily for 12 weeks). Brand-name Lamisil costs significantly more—often $500+—but generic versions are bioequivalent and work identically. Add $50-150 for required liver function monitoring tests. Total out-of-pocket cost for the complete treatment: $65-195 without insurance.
Direct Answer: Yes, combination therapy using both oral and topical antifungals together can improve cure rates by 15-20 percentage points, particularly for severe infections affecting more than 75% of the nail.
Health Evolves reports that combination therapy achieves the highest success rates and lowers recurrence risk. The oral medication attacks fungus through your bloodstream while the topical provides additional antifungal activity at the nail surface. However, this approach significantly increases cost (potentially $4,000+ for topical plus oral medication) and most insurance plans require documented failure of oral monotherapy before approving combination treatment.
Direct Answer: Yes, baseline liver function tests (AST and ALT) are required before starting oral antifungals, with potential rechecking at 6 weeks if symptoms develop.
All oral antifungals can cause liver enzyme elevations. Your doctor needs baseline values to compare against if you develop symptoms during treatment. The tests cost $25-75 and are typically covered by insurance. Some providers also order a complete blood count and confirm fungal diagnosis with culture or PCR testing before prescribing—especially important since up to 50% of nail dystrophy is non-fungal.
Direct Answer: The medication killed the fungus, but the damaged nail remains until it grows out completely—a process taking 12-18 months for toenails even after successful treatment.
, toenails grow at just 1.6mm per month. Your 12-week course of terbinafine eradicated the infection, but you're looking at another 9-15 months of waiting for clear nail to grow from cuticle to free edge and replace the discolored, thickened nail. This is normal and doesn't mean treatment failed. Follow-up testing at 6 months can confirm the fungus is gone even if appearance hasn't fully normalized.
Direct Answer: Yes, terbinafine achieves a 38% complete cure rate versus itraconazole's 14% rate, making it 2.7× more effective for nail fungus treatment.
shows terbinafine's clear superiority in cure rates. Terbinafine also has fewer serious drug interactions than itraconazole, which carries a black box warning for heart failure and interacts dangerously with statins, blood thinners, and many cardiac medications. The main advantage of itraconazole is pulse therapy—only 21-28 days of actual medication versus 84 days with terbinafine—but the lower cure rate makes it a second-line option.
Direct Answer: Recurrence rates range from 10-53% within three years, with Scripps Health reporting recurrence rates as high as 40% after successful treatment.
Reinfection happens through contaminated shoes, socks, nail tools, or concurrent athlete's foot. The CDC notes people with diabetes face increased risk for returning infections. Preventing recurrence requires treating any foot fungus, disinfecting footwear with antifungal spray, using antifungal powder in shoes, keeping nails trimmed short, and avoiding walking barefoot in public areas like gym showers and pool decks.
Direct Answer: Moderate alcohol consumption is generally acceptable with terbinafine, but heavy drinking increases the risk of liver toxicity and should be avoided during treatment.
Both terbinafine and alcohol are metabolized by the liver. While occasional drinks don't significantly increase risk in patients with normal liver function, regular heavy drinking combined with oral antifungals can stress the liver and increase the chance of elevated liver enzymes. If you drink regularly, discuss this with your doctor before starting treatment—they may recommend more frequent liver function monitoring or suggest topical treatment instead.
The cure rate data tells a clear story: oral terbinafine delivers 38% complete clearance for $15-45 over 12 weeks. Topical prescriptions achieve 6.5-17.8% cure rates for $1,800-4,700 over 48 weeks.
The math isn't close.
If you can tolerate oral medication—meaning you have normal liver function, no heart failure, and manageable drug interactions—terbinafine is the evidence-based choice. Generic pricing makes it accessible even without insurance.
For patients who can't take oral antifungals due to liver disease, serious drug interactions, or pregnancy, topical prescriptions provide an alternative despite modest cure rates. Combination therapy may be worth considering for severe infections, though cost and insurance coverage create barriers.
According to research, onychomycosis affects over 20% of adults over age 60 and more than 50% of people over age 70. You're not alone in dealing with this infection. But you need realistic expectations: even the best treatment requires 12-18 months from start to completely clear nail.
Start with confirmed diagnosis through fungal culture or PCR testing. Get baseline liver function tests. Choose the treatment approach that fits your health status, medication list, and budget. Then commit to the full timeline—both the medication course and the months of nail regrowth that follow.
The alternative is living with progressively worsening nail fungus that can spread to other nails, cause pain, and increase infection risk. Treatment works, but only if you start.
Ready to explore prescription treatment options? STRIDE offers doctor-supervised combination therapy through a convenient telehealth platform, making it easier to get started without multiple office visits.